We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4980:TSEDexerials Corp. Analysis

Data as of 2026-05-22 - not real-time

NT$49.60

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Jorjin Technologies is trading at TWD 49.6, comfortably above its 20‑day (TWD 40.6), 50‑day (TWD 33.3) and 200‑day (TWD 30.2) simple moving averages, indicating a strong bullish bias. The MACD line sits at 4.88 above its signal at 3.82, reinforcing the bullish momentum, while the RSI of 65 suggests the stock is approaching overbought territory. Volume is on an increasing trend, supporting the price advance, but the 30‑day volatility of 144% signals a highly erratic price path. Despite a staggering 96.8% year‑over‑year revenue growth and a healthy gross margin of 63%, operating cash flow (‑TWD 56.5 M) and free cash flow (‑TWD 63.8 M) remain negative, raising concerns about cash sustainability. The PE ratio of 451 dwarfs the industry average of 39, flagging the stock as severely overvalued, while the PB multiple of 2.96 and lack of dividend further diminish income‑focused appeal. With a low beta of 0.53, market‑wide swings have limited impact, yet the combination of high volatility, thin profitability, and elevated valuation suggests caution for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above all major SMAs indicating bullish trend
  • RSI near overbought levels and extreme short‑term volatility
  • Increasing volume supporting current price movement

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Robust revenue growth but persistent negative cash flow
  • Severe overvaluation relative to industry peers
  • Low beta limiting market‑wide risk exposure

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • PE ratio far above sector average indicating unsustainable pricing
  • Weak profitability metrics (low profit margin, negative ROA)
  • High volatility and lack of dividend reducing long‑term appeal

Key Metrics & Analysis

Financial Health

Revenue Growth96.80%
Profit Margin2.59%
P/E Ratio450.9
ROE0.65%
ROA-0.29%
Debt/Equity3.64
P/B Ratio3.0
Op. Cash FlowNT$-56528000
Free Cash FlowNT$-63754500
Industry P/E39.1

Technical Analysis

TrendBullish
RSI65.3
SupportNT$30.15
ResistanceNT$57.60
MA 20NT$40.60
MA 50NT$33.26
MA 200NT$30.18
MACDBullish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.53
Volatility143.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.